Mei Qiu

1.3k total citations
63 papers, 935 citations indexed

About

Mei Qiu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Mei Qiu has authored 63 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in Mei Qiu's work include Diabetes Treatment and Management (30 papers), Metabolism, Diabetes, and Cancer (14 papers) and Diabetes Management and Research (10 papers). Mei Qiu is often cited by papers focused on Diabetes Treatment and Management (30 papers), Metabolism, Diabetes, and Cancer (14 papers) and Diabetes Management and Research (10 papers). Mei Qiu collaborates with scholars based in China, United States and Israel. Mei Qiu's co-authors include Liang‐Liang Ding, Hairong Zhou, Rong Liu, Xiulian Wang, Michael C. Chen, Jun Lu, Xuying Sun, Yan Xiong, Jian‐Zhi Wang and Miao Zhang and has published in prestigious journals such as Nature Communications, PLoS ONE and Current Biology.

In The Last Decade

Mei Qiu

54 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Qiu China 15 246 230 227 153 152 63 935
Carmelo Quarta Italy 18 159 0.6× 180 0.8× 387 1.7× 98 0.6× 142 0.9× 38 1.1k
M. Gail Murphy United States 21 270 1.1× 121 0.5× 350 1.5× 222 1.5× 313 2.1× 43 1.3k
Brina Snyder United States 11 333 1.4× 170 0.7× 317 1.4× 37 0.2× 103 0.7× 11 1.1k
Daniela S. Razolli Brazil 18 295 1.2× 219 1.0× 468 2.1× 73 0.5× 143 0.9× 31 1.2k
Melissa A. Burmeister United States 18 361 1.5× 399 1.7× 294 1.3× 237 1.5× 314 2.1× 34 1.2k
Jean‐Baptiste Roullet United States 16 371 1.5× 85 0.4× 175 0.8× 167 1.1× 175 1.2× 52 901
Juan Antonio García-Arnés Spain 23 233 0.9× 378 1.6× 496 2.2× 70 0.5× 346 2.3× 54 1.3k
Koro Gotoh Japan 21 294 1.2× 328 1.4× 511 2.3× 138 0.9× 374 2.5× 59 1.6k
Beatriz Merino Spain 16 132 0.5× 67 0.3× 397 1.7× 118 0.8× 161 1.1× 41 900
Carol Lam Canada 16 283 1.2× 307 1.3× 510 2.2× 93 0.6× 426 2.8× 26 1.2k

Countries citing papers authored by Mei Qiu

Since Specialization
Citations

This map shows the geographic impact of Mei Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Qiu more than expected).

Fields of papers citing papers by Mei Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Qiu. The network helps show where Mei Qiu may publish in the future.

Co-authorship network of co-authors of Mei Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Qiu. A scholar is included among the top collaborators of Mei Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Qiu. Mei Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Mei, et al.. (2023). Concerns regarding the reliability of subgroup effects. EClinicalMedicine. 56. 101794–101794. 1 indexed citations
2.
3.
Qiu, Mei, Liang‐Liang Ding, Miao Zhang, & Hairong Zhou. (2021). Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors. Diabetes and Vascular Disease Research. 18(2). 1476853704–1476853704. 62 indexed citations
4.
5.
Qiu, Mei, Liang‐Liang Ding, & Hairong Zhou. (2021). Effects of SGLT2 inhibitors on cardiovascular and renal outcomes in type 2 diabetes. Medicine. 100(10). e25121–e25121. 14 indexed citations
6.
Qiu, Mei, et al.. (2021). Impact of time factor and patient characteristics on the efficacy of PCI vs CABG for left main coronary disease. Medicine. 100(10). e25057–e25057. 3 indexed citations
7.
8.
Qiu, Mei, Liang‐Liang Ding, & Hairong Zhou. (2021). Comparative Efficacy of Five SGLT2i on Cardiorenal Events: A Network Meta-analysis Based on Ten CVOTs. American Journal of Cardiovascular Drugs. 22(1). 69–81. 7 indexed citations
9.
10.
Zhao, Limin, et al.. (2021). Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial. Therapeutic Advances in Endocrinology and Metabolism. 12. 2425414225–2425414225. 2 indexed citations
11.
Ding, Liang‐Liang, et al.. (2021). Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials. Endocrine Journal. 68(6). 739–742. 24 indexed citations
12.
Qiu, Mei, et al.. (2021). Meta-Analysis of the Effects of Four Factors on the Efficacy of SGLT2 Inhibitors in Patients with HFrEF. ESC Heart Failure. 8(2). 1722–1724. 2 indexed citations
13.
Qiu, Mei, Shu-Yan Liu, & Hairong Zhou. (2021). Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation. Medicine. 100(1). e24188–e24188. 2 indexed citations
14.
15.
Ding, Liang‐Liang, et al.. (2020). Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data. Osteoporosis International. 31(5). 961–971. 17 indexed citations
16.
17.
18.
Qiu, Mei, Liang‐Liang Ding, Wei Xu-bin, Wei Wei, & Hairong Zhou. (2020). Effects of glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors on major adverse cardiovascular events in type 2 diabetes by race, ethnicity, and region. Medicine. 99(49). e23489–e23489. 9 indexed citations
19.
Qiu, Mei, Liang‐Liang Ding, Miao Zhang, & Hairong Zhou. (2020). Comparison of the risk of SGLT2is and NonSGLT2is in leading to amputation: A network meta-analysis. Journal of Diabetes and its Complications. 35(2). 107803–107803. 6 indexed citations
20.
Xiong, Yan, Xinwen Zhou, Xiulian Wang, et al.. (2012). Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation. Neurobiology of Aging. 34(3). 745–756. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmelo Quarta Breakdown of academic impact, for papers by M. Gail Murphy Breakdown of academic impact, for papers by Brina Snyder Breakdown of academic impact, for papers by Daniela S. Razolli Breakdown of academic impact, for papers by Melissa A. Burmeister Breakdown of academic impact, for papers by Jean‐Baptiste Roullet Breakdown of academic impact, for papers by Juan Antonio García-Arnés Breakdown of academic impact, for papers by Koro Gotoh Breakdown of academic impact, for papers by Beatriz Merino Breakdown of academic impact, for papers by Carol Lam
Rankless by CCL
2026